Re-treatment of patients refractory to daratumumab
Heinz Ludwig et al.
Features of high-risk multiple myeloma and how to treat it
TGR-1202 in CLL and non-Hodgkin lymphoma
The basis for immunotherapy in multiple myeloma
Ignacio Melero Bermejo
The future of multiple myeloma treatment: genetic tests and frailty